The MP-eye is just the first product in a range of areas of ophthalmic screening devices that azul plans to develop. Following the success of the MP-eye, the next step in our mission to prevent sight-loss is to set our sights on those whose sight is affected by diabetes and amblyopia.

Contact us today if you are interested in becoming an investor.